DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Development Award
This opportunity funds therapeutic development for amyotrophic lateral sclerosis (ALS), from preclinical validation through FDA IND-enabling work. Projects must be product-driven and already have lead compounds plus proof-of-concept efficacy in relevant ALS cellular and whole-animal models. Mechanism-specific, predictive biomarkers tied to target engagement and pharmacodynamics are a critical …
Source
Award
Dates
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
-
DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Idea Award
Dept. of the Army -- USAMRAA
-
Biomedical Research Projects
Motor Neurone Disease Association
-
DoW Arthritis Clinical Research Award
Dept. of the Army -- USAMRAA
-
DoW Duchenne Muscular Dystrophy, Clinical/Translational Research Award
Defense Health Agency Contracting Activity - DHACA
-
Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimer’s Disease and Related Dementias (R01 Clinical Trial Not Allowed)
National Institutes of Health ▸ National Institute on Aging
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers